Goldman Sachs Group »

Sensei Biotherapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Sensei Biotherapeutics (SNSE) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Sensei Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sensei Biotherapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sensei Biotherapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.9M 62k 31.52

More positions owned by Goldman Sachs Group

Nvidia Corporation CMN (NVDA)
State Str Spdr S&p 500 Etf T CMN (SPY)
Apple CMN (AAPL)
Microsoft Corp CMN (MSFT)
Alphabet CMN (GOOGL)
Amazon CMN (AMZN)
Tesla CMN (TSLA)
Broadcom CMN (AVGO)
Meta Platforms CMN (META)
Invesco Qqq Tr CMN (QQQ)
Alphabet CMN (GOOG)
Ishares Tr CMN (IVV)
Vanguard Index Fds CMN (VOO)
Ishares Tr CMN (HYG)
Taiwan Semiconductor Manufac CMN (TSM)

View all positions for Goldman Sachs Group

Top funds holding Sensei Biotherapeutics

Vivo Capital
Cormorant Asset Management
Millennium Management
Franklin Resources
Stempoint Capital
Trails Edge Capital Partners
Goldman Sachs Group
Hrt Financial
Suvretta Capital Management
Bank of America Corporation
Logos Global Management
Boothbay Fund Management
Brevan Howard Capital Management
Fred Alger Management
Balyasny Asset Management

View all funds holding Sensei Biotherapeutics